Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

ACTIVE_NOT_RECRUITING
A Phase 2 Study of Belzutifan (PT2977, MK-6482) for the Treatment of Von Hippel Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC) (MK-6482-004)
Description

This study is designed to investigate belzutifan as a treatment for VHL disease associated RCC.